257 related articles for article (PubMed ID: 31824147)
21. C-reactive protein levels in stable COPD patients: a case-control study.
Silva DR; Gazzana MB; Knorst MM
Int J Chron Obstruct Pulmon Dis; 2015; 10():1719-25. PubMed ID: 26357470
[TBL] [Abstract][Full Text] [Related]
22. Defining the role of exertional hypoxemia and pulmonary vasoconstriction on lung function decline, morbidity, and mortality in patients with chronic obstructive lung disease - the PROSA study: rationale and study design.
Böger R; Hannemann J
BMC Pulm Med; 2024 May; 24(1):262. PubMed ID: 38816826
[TBL] [Abstract][Full Text] [Related]
23. Can we predict the prognosis of COPD with a routine blood test?
Xiong W; Xu M; Zhao Y; Wu X; Pudasaini B; Liu JM
Int J Chron Obstruct Pulmon Dis; 2017; 12():615-625. PubMed ID: 28243079
[TBL] [Abstract][Full Text] [Related]
24. Serum cytokine profiling and enrichment analysis reveal the involvement of immunological and inflammatory pathways in stable patients with chronic obstructive pulmonary disease.
Bade G; Khan MA; Srivastava AK; Khare P; Solaiappan KK; Guleria R; Palaniyar N; Talwar A
Int J Chron Obstruct Pulmon Dis; 2014; 9():759-73. PubMed ID: 25125975
[TBL] [Abstract][Full Text] [Related]
25. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
[TBL] [Abstract][Full Text] [Related]
26. The EFFECT trial: evaluating exacerbations, biomarkers, and safety outcomes with two dose levels of fluticasone propionate/formoterol in COPD.
Papi A; Jones PW; Dalvi PS; McAulay K; McIver T; Dissanayake S
Int J Chron Obstruct Pulmon Dis; 2015; 10():2431-8. PubMed ID: 26648706
[TBL] [Abstract][Full Text] [Related]
27. Anemia and Adverse Outcomes in a Chronic Obstructive Pulmonary Disease Population with a High Burden of Comorbidities. An Analysis from SPIROMICS.
Putcha N; Fawzy A; Paul GG; Lambert AA; Psoter KJ; Sidhaye VK; Woo J; Wells JM; Labaki WW; Doerschuk CM; Kanner RE; Han MK; Martinez C; Paulin LM; Martinez FJ; Wise RA; O'Neal WK; Barr RG; Hansel NN;
Ann Am Thorac Soc; 2018 Jun; 15(6):710-717. PubMed ID: 30726108
[TBL] [Abstract][Full Text] [Related]
28. Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.
de Llano LP; Cosío BG; Iglesias A; de Las Cuevas N; Soler-Cataluña JJ; Izquierdo JL; López-Campos JL; Calero C; Plaza V; Miravitlles M; Torrego A; Martinez-Moragon E; Soriano JB; Viña AL; Bobolea I
Int J Chron Obstruct Pulmon Dis; 2018; 13():591-601. PubMed ID: 29483774
[TBL] [Abstract][Full Text] [Related]
29. Association between preserved ratio impaired spirometry and sleep apnea in a Chinese community.
Zhang C; Wei S; Wang Y; Yu K; Jin Z; Zhang M; Ma X; Zhang C; Zhang Q; Sun K; Zhou P; Zhong Y; Ma J; Liao J; Wang G
Curr Med Res Opin; 2023 Apr; 39(4):621-626. PubMed ID: 36847254
[TBL] [Abstract][Full Text] [Related]
30. Airway regulatory T cells are decreased in COPD with a rapid decline in lung function.
Eriksson Ström J; Pourazar J; Linder R; Blomberg A; Lindberg A; Bucht A; Behndig AF
Respir Res; 2020 Dec; 21(1):330. PubMed ID: 33317530
[TBL] [Abstract][Full Text] [Related]
31. Drop in lung function during asthma and COPD exacerbations - can it be assessed without spirometry?
Melbye H; Al-Ani S; Spigt M
Int J Chron Obstruct Pulmon Dis; 2016; 11():3145-3152. PubMed ID: 27994453
[TBL] [Abstract][Full Text] [Related]
32. Exhaled Breath Temperature as a Novel Marker of Future Development of COPD: Results of a Follow-Up Study in Smokers.
Labor M; Vrbica Ž; Gudelj I; Labor S; Jurić I; Plavec D
COPD; 2016 Dec; 13(6):741-749. PubMed ID: 27078073
[TBL] [Abstract][Full Text] [Related]
33. Inflammatory mediators in exhaled breath condensate and peripheral blood of healthy donors and stable COPD patients.
Hao W; Li M; Zhang C; Zhang Y; Wang P
Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):224-230. PubMed ID: 31046512
[No Abstract] [Full Text] [Related]
34. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD
Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804
[TBL] [Abstract][Full Text] [Related]
35. Multicenter study of the COPD-6 screening device: feasible for early detection of chronic obstructive pulmonary disease in primary care?
Kjeldgaard P; Lykkegaard J; Spillemose H; Ulrik CS
Int J Chron Obstruct Pulmon Dis; 2017; 12():2323-2331. PubMed ID: 28831249
[TBL] [Abstract][Full Text] [Related]
36. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.
Lange P; Çolak Y; Ingebrigtsen TS; Vestbo J; Marott JL
Lancet Respir Med; 2016 Jun; 4(6):454-62. PubMed ID: 27061878
[TBL] [Abstract][Full Text] [Related]
37. Blood biomarkers as predictors of long-term mortality in COPD.
Mendy A; Forno E; Niyonsenga T; Gasana J
Clin Respir J; 2018 May; 12(5):1891-1899. PubMed ID: 29227024
[TBL] [Abstract][Full Text] [Related]
38. Inter-alpha-trypsin inhibitor heavy chain 4: a novel biomarker for environmental exposure to particulate air pollution in patients with chronic obstructive pulmonary disease.
Lee KY; Feng PH; Ho SC; Chuang KJ; Chen TT; Su CL; Liu WT; Chuang HC
Int J Chron Obstruct Pulmon Dis; 2015; 10():831-41. PubMed ID: 25977605
[TBL] [Abstract][Full Text] [Related]
39. Prevalence, risk factors, and health-related quality of life of osteoporosis in patients with COPD at a community hospital in Taiwan.
Lin CW; Chen YY; Chen YJ; Liang CY; Lin MS; Chen W
Int J Chron Obstruct Pulmon Dis; 2015; 10():1493-500. PubMed ID: 26251589
[TBL] [Abstract][Full Text] [Related]
40. Positive correlation of airway resistance and serum asymmetric dimethylarginine level in COPD patients with systemic markers of low-grade inflammation.
Tajti G; Gesztelyi R; Pak K; Papp C; Keki S; Szilasi ME; Mikaczo A; Fodor A; Szilasi M; Zsuga J
Int J Chron Obstruct Pulmon Dis; 2017; 12():873-884. PubMed ID: 28352168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
